Literature DB >> 16286794

Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis.

Stefan Mennel1, Carsten H Meyer, Fred Eggarter, Silvia Peter.   

Abstract

OBJECTIVE: To describe fundus autofluorescence (AF), fluorescein angiography (FA) and indocyanine green angiography (ICGA) in different types of retinal astrocytic hamartomas in tuberous sclerosis (Morbus Bourneville-Pringle).
METHODS: Two eyes with 8 lesions, i.e. type 1 (n = 7) and type 3 (n = 1), were examined. AF pictures were taken prior to injection, FA and ICGA images were obtained in the early and the late phase. To achieve additional cases, a systematic literature review with exten- sive Internet and library search was performed.
RESULTS: Strong AF was seen in type 2 and type 3 retinal astrocytic hamartomas, whereas type 1 lesions blocked the physiologic fundus AF. Fluorescence angiography of all types of lesions revealed hypofluorescence in early frames and hyperfluorescence originating from leakage in late frames. ICGA showed a subtle blockade in type 1, a total blockade in type 2 and in the central part and a partial blockade in the peripheral part in type 3 lesions.
CONCLUSIONS: Retinal astrocytic hamartomas in tuberous sclerosis can be easily detected by angiography, especially type 1 lesions which are difficult to visualize by funduscopy. Early- and late-phase fluorescein angiography and ICGA are helpful to differentiate the three lesion types. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286794     DOI: 10.1159/000088377

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  9 in total

1.  Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab.

Authors:  M Nakayama; H Keino; A Hirakata; A A Okada; Y Terado
Journal:  Eye (Lond)       Date:  2012-06-22       Impact factor: 3.775

2.  [Current treatment indications and treatment options for retinal astrocytic hamartoma].

Authors:  S Mennel; S Peter; J C Schmidt; C H Meyer
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  Infrared imaging and optical coherence tomography reveal early-stage astrocytic hamartomas not detectable by fundoscopy.

Authors:  Luna Xu; Tomas R Burke; Jonathan P Greenberg; Vinit B Mahajan; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2012-02-04       Impact factor: 5.258

4.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

5.  Glial tumors of the retina. The 2009 King Khaled Memorial Lecture.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Saudi J Ophthalmol       Date:  2009-10-24

Review 6.  [Retinal tumors in adults: Part 2 nonvascular tumors of retina and retinal pigment epithelium].

Authors:  Roya Piria; Felix Rommel; Michael Zimbelmann; Kristina Erikson; Neele Babst; Anton Brosig; Josephine Christin Freitag; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologe       Date:  2021-07-29       Impact factor: 1.059

7.  Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa.

Authors:  Michael Kinori; Iris Moroz; Ygal Rotenstreich; Hagith Yonath; Ido Didi Fabian; Vicktoria Vishnevskia-Dai
Journal:  Clin Ophthalmol       Date:  2011-11-24

8.  Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).

Authors:  Martin Pencak; Jan Krasny; Miroslav Veith; Magdalena Vokrojova
Journal:  BMC Ophthalmol       Date:  2016-11-11       Impact factor: 2.209

9.  Peripheral bright streaks in tuberous sclerosis.

Authors:  Torgerð Hentze Eliesersdóttir; Elin Holm; Christina Eckmann-Hansen; Marie Wistrup Torm; Mohamed Belmouhand; Michael Larsen
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.